Skip to Content
ETFs

Invesco Dynamic Biotechnology & Genome ETF

PBE
$--
Today’s Change
-- (--)

Snapshot
*

Inception Date
Jun 23 2005
Expense Ratio
0.59%
Type
US Equities
Fund Owner
Invesco
Volume (1m avg. daily)
$373,807
AUM
$250,197,028
Associated Index
Dynamic Biotechnology & Genome Intellidex Index
Inverse/Leveraged
No
Passive/Active
Passive
Fractionable on Composer
Yes
Prospectus
View

Top 10 Holdings

VRTX
Vertex Pharmaceuticals, Inc.
5.32%
REGN
Regeneron Pharmaceuticals, Inc.
5.26%
BIIB
Biogen Inc
5.09%
AMGN
AMGEN Inc.
5.07%
INCY
Incyte Corp.
4.93%
GILD
Gilead Sciences, Inc.
4.80%
BMRN
Biomarin Pharmaceutical Inc. - Registered Shares
4.55%
UTHR
United Therapeutics Corp
4.53%
CDMO
Avid Bioservices Inc
3.29%
ACAD
Acadia Pharmaceuticals Inc
3.05%
Invest with PBE

What is PBE?

The Invesco Dynamic Biotechnology & Genome ETF (Fund) is based on the Dynamic Biotech & Genome Intellidex Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances in biotechnology and genetic engineering and research. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.

ETFs related toPBE

ETFs correlated to PBE include IBB, BIB, FBT

PBE
Invesco Capital Management LLC - Invesco Dynamic Biotechnology & Genome ETF
IBB
BlackRock Institutional Trust Company N.A. - iShares Biotechnology ETF
BIB
ProShares Trust - ProShares Ultra Nasdaq Biotechnology 2X Shares
FBT
First Trust Exchange-Traded Fund III - First Trust NYSE Arca Biotechnology Index Fund
XBI
SPDR Series Trust - SPDR Biotech ETF
LABU
Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X Shares
BBH
VanEck ETF Trust - VanEck Biotech ETF
GNOM
Global X Funds - Global X Genomics & Biotechnology ETF
XPH
SPDR Series Trust - SPDR Pharmaceuticals ETF
FXH
First Trust Exchange-Traded Fund III - First Trust Health Care AlphaDEX Fund
ARKG
ARK Investment Management LLC - ARK Genomic Revolution ETF

What is ETF correlation?

Correlation is a measure of the strength of the relationship between two ETFs. It quantifies the degree to which prices of the two ETFs typically move together.

Here, correlation is measured over the past year with the Pearson correlation coefficient (Pearon’s r), which ranges from -1 to 1.

Using ETF correlations in portfolio and strategy construction

ETF correlations can help you create investing strategies and portfolios. Use them to:

  • •Build a diversified portfolio from uncorrelated or inversely correlated ETFs with the aim of minimizing portfolio risk.
  • •Compare correlated or related ETFs to find one with a lower expense ratio or higher trading volume.
  • •Create an investing strategy that hedges an ETF with an uncorrelated or inversely correlated ETF.

FAQ

PBE is a US Equities ETF. The Invesco Dynamic Biotechnology & Genome ETF (Fund) is based on the Dynamic Biotech & Genome Intellidex Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances in biotechnology and genetic engineering and research. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.

PBE tracks the Dynamic Biotechnology & Genome Intellidex Index.

No, PBE is not actively managed. It is passively managed. In an actively managed fund, the fund manager makes decisions about how funds are invested. A passively managed fund typically tries to track or follow a market index.

Yes, PBE is passively managed. A passively managed fund typically tries to track or follow a market index. In an actively managed fund, the fund manager makes decisions about how funds are invested.

The 1-month return on PBE is -0.0623%. This is the percent change in the value of PBE over the most recent 1-month period. The 3-month return on PBE is -0.0412%. This is the percent change in the value of PBE over the most recent 3-month period.

The standard deviation of PBE for the past year is 0.2789%. Standard deviation is the typical amount that the daily returns vary from the mean of the returns over the time period, standardized to a period of a year.

ETFs similar to PBE include XLK, XLU, and XLY.

ETFs correlated to PBE include IBB, BIB, and FBT.

ETFs that are inversely correlated to PBE include LABD, RWM, and SRTY.

Disclaimers

*

We show information directly obtained from our data provider, Xignite. Data shown here is provided by Xignite, an unaffiliated third party. Composer believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate.

**

We show information based on calculations performed by Composer using data from our provider. Information provided here is based on calculations performed by Composer using data sourced from Xignite, an unaffiliated third party. Composer believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.